TR200402024T4 - Maddelerin hormon etkisini test yöntemi - Google Patents

Maddelerin hormon etkisini test yöntemi

Info

Publication number
TR200402024T4
TR200402024T4 TR2004/02024T TR200402024T TR200402024T4 TR 200402024 T4 TR200402024 T4 TR 200402024T4 TR 2004/02024 T TR2004/02024 T TR 2004/02024T TR 200402024 T TR200402024 T TR 200402024T TR 200402024 T4 TR200402024 T4 TR 200402024T4
Authority
TR
Turkey
Prior art keywords
protein
dna
arap11
fragments
substances
Prior art date
Application number
TR2004/02024T
Other languages
English (en)
Inventor
Obendorf Maik
Schroder Jens
Wolf Siegmund
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10121710A external-priority patent/DE10121710A1/de
Priority claimed from DE2001161325 external-priority patent/DE10161325A1/de
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of TR200402024T4 publication Critical patent/TR200402024T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bulus, maddelerin hormon etkisinin test edilmesi için bir yöntem, nükleer reseptörlerin komodülasyon mekanizmasindaki bozukluklarin tespit edilmesi için bir yöntem ve özellikle insan androjen reseptörü ve diger nükleer reseptörler için ARAP11 koaktivatörü ile bunlara ait kodlayici DNA'lar gibi uygun araçlarla ilgilidir
TR2004/02024T 2001-05-04 2002-04-29 Maddelerin hormon etkisini test yöntemi TR200402024T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10121710A DE10121710A1 (de) 2001-05-04 2001-05-04 Verfahren zur Testung des hormonellen Effekts von Substanzen
DE2001161325 DE10161325A1 (de) 2001-12-13 2001-12-13 Verfahren zur Testung des hormonellen Effekts von Substanzen

Publications (1)

Publication Number Publication Date
TR200402024T4 true TR200402024T4 (tr) 2004-09-21

Family

ID=26009230

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02024T TR200402024T4 (tr) 2001-05-04 2002-04-29 Maddelerin hormon etkisini test yöntemi

Country Status (10)

Country Link
US (1) US20030124508A1 (tr)
EP (1) EP1255113B1 (tr)
JP (1) JP4071033B2 (tr)
AT (1) ATE267402T1 (tr)
DE (1) DE50200452D1 (tr)
DK (1) DK1255113T3 (tr)
ES (1) ES2219601T3 (tr)
NO (1) NO20021900L (tr)
PT (1) PT1255113E (tr)
TR (1) TR200402024T4 (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10226674B4 (de) * 2002-06-12 2006-01-05 Schering Ag Verfahren zur Testung des hormonellen Effekts von Substanzen
DE10226675B4 (de) * 2002-06-12 2006-01-05 Schering Ag Verfahren zur Testung des hormonellen Effekts von Substanzen
EP2316328B1 (en) 2003-09-15 2012-05-09 Super Dimension Ltd. Wrap-around holding device for use with bronchoscopes
US9089261B2 (en) 2003-09-15 2015-07-28 Covidien Lp System of accessories for use with bronchoscopes
US8764725B2 (en) 2004-02-09 2014-07-01 Covidien Lp Directional anchoring mechanism, method and applications thereof
US7655700B2 (en) 2005-08-25 2010-02-02 Michigan State University Transgenic mouse model and methods for treatment of neuro muscular disease by interfering with androgen-androgen receptor interaction in skeletal muscles
US8905920B2 (en) 2007-09-27 2014-12-09 Covidien Lp Bronchoscope adapter and method
US8932207B2 (en) 2008-07-10 2015-01-13 Covidien Lp Integrated multi-functional endoscopic tool
WO2011159834A1 (en) 2010-06-15 2011-12-22 Superdimension, Ltd. Locatable expandable working channel and method
US10952593B2 (en) 2014-06-10 2021-03-23 Covidien Lp Bronchoscope adapter
US10426555B2 (en) 2015-06-03 2019-10-01 Covidien Lp Medical instrument with sensor for use in a system and method for electromagnetic navigation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506102A (en) * 1993-10-28 1996-04-09 Ligand Pharmaceuticals Incorporated Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription

Also Published As

Publication number Publication date
DE50200452D1 (de) 2004-06-24
DK1255113T3 (da) 2004-10-04
ATE267402T1 (de) 2004-06-15
PT1255113E (pt) 2004-10-29
NO20021900D0 (no) 2002-04-22
NO20021900L (no) 2002-11-05
JP2003018996A (ja) 2003-01-21
US20030124508A1 (en) 2003-07-03
ES2219601T3 (es) 2004-12-01
JP4071033B2 (ja) 2008-04-02
EP1255113B1 (de) 2004-05-19
EP1255113A1 (de) 2002-11-06

Similar Documents

Publication Publication Date Title
Cervellati et al. Oxidative damage and the pathogenesis of menopause related disturbances and diseases
Kloepper et al. Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture
Chen et al. The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim
Bermont et al. Regulation of vascular endothelial growth factor expression by insulin‐like growth factor‐I in endometrial adenocarcinoma cells
TR200402024T4 (tr) Maddelerin hormon etkisini test yöntemi
NO984856L (no) Innretning for kvalitativ og/eller kvantitativ analyse av analytter, basert pÕ f°lsom magnetisk deteksjon
DE60106228D1 (de) Elektrochemischer biosensor-teststreifen mit erkennungselektrode und auslesemessgerät, das diesen teststreifen verwendet
ATE378418T1 (de) Extrazelluläres, neues rage-bindendes protein (en-rage) und dessen verwendungen
Casbarra et al. Conformational analysis of HAMLET, the folding variant of human α‐lactalbumin associated with apoptosis
Steinkellner et al. A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels
ATE490469T1 (de) Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden
Dargaud et al. Global haemostasis and point of care testing
Ingram et al. Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse
JP2005537027A5 (tr)
Kito et al. Downregulation of the Ca2+-activated K+ channel KCa3. 1 in mouse preosteoblast cells treated with vitamin D receptor agonist
CA2377815C (en) Fluorescent intensity method for assaying binding between proteins or peptides
Nordlund et al. Progastrin-releasing peptide: stability in plasma/serum and upper reference limit
DE50300480D1 (de) Verfahren zur Testung des hormonellen Effekts von Substanzen
Segerer et al. Increased insulin concentrations during growth hormone treatment in girls with Turner syndrome are ameliorated by hormone replacement therapy
BR9815090A (pt) "moléculas de ácido nucléico correlacionadas com o fenótipo rhesus d fraco"
Shi et al. Activation of renal renin-angiotensin system in upstream stimulatory factor 2 transgenic mice
Qi et al. Extracellular and intracellular angiotensin II regulate the automaticity of developing cardiomyocytes via different signaling pathways
PT1376136E (pt) Processo para testar o efeito hormonal de substancias
Moura-Assis et al. POMC-specific knockdown of Tril reduces body adiposity and increases hypothalamic leptin responsiveness
Athamneh et al. Proteomic studies in VWA1‐related neuromyopathy allowed new pathophysiological insights and the definition of blood biomarkers